• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Lung CAD makes further improvements


Computer-aided detection is scoring new points for lung cancer diagnosis, according to European researchers. Despite ongoing controversy, investigators also showed advances in CAD for lung cancer screening.

Computer-aided detection is scoring new points for lung cancer diagnosis, according to European researchers. Despite ongoing controversy, investigators also showed advances in CAD for lung cancer screening.

A number of preliminary studies published in clinical journals in late 2004 or presented at last year's RSNA meeting showed promising results for CAD's sensitivity in combination with multislice CT. The latest data presented earlier this year at the European Congress of Radiology corroborate findings and highlight gains in workflow.

Dr. Dag Wormanns and colleagues at the University Hospital of Münster in Germany assessed randomly 50 MSCT scans of the chest. Two independent radiologists (A and B) read scans using CAD as a concurrent reader twice with a one-week gap between readings. In addition to sensitivity, the investigators recorded the times needed for concurrent reading with CAD, for second reading without CAD, and for CAD alone as second opinion. They found the use of CAD for second opinion was the best bet for improving sensitivity and workflow.

CAD used as a concurrent reader could save reporting time, but it may do so at the expense of some sensitivity. If the clinical setting demands higher sensitivity values, CAD should be used for a second opinion instead. Even though reporting time increased when CAD was used as a second reader, so did sensitivity, Wormanns said.

Using CAD, the German team detected a total of 225 nodules. Sensitivity values recorded for CAD as a concurrent versus second opinion reading were 52% versus 57% and 69% versus 74% for radiologists A and B, respectively. The average reporting time was 206 seconds versus 251 sececonds for concurrent and second reading, respectively. The difference was statistically significant (p

Although the study is a step ahead, there are challenges. The integration of CAD systems in the reporting workflow is not straightforward. The most desirable way of integration -as concurrent reader - requires even more sensitive CAD systems, Wormanns said.

In another study, Spanish investigators reported on a CAD system's impact on a lung cancer screening program. Principal investigator Dr. Gorka Bastarrika and colleagues enrolled 114 patients who underwent low-dose MSCT exams of the chest. An experienced radiologist and a radiology resident read the studies in addition to the CAD system. They found CAD increased the sensitivity of the low-dose MSCT protocol, changed patient management in several cases, and significantly reduced the time needed to read thin-section MSCT scans.

Since the first study published by the Early Lung Cancer Action Project group, many studies have been performed to determine whether early lung cancer detection with low-dose CT is feasible. The Spanish investigators confirmed that MSCT's improved spatial and temporal resolution increases the sensitivity for detection of small pulmonary nodules, even with low-radiation-dose (20 mAs) protocols.

They noted an important drawback, however. Thin-slice scanning significantly increases the number of images and thus interpretation time. A CAD system could be used in this setting as a second-reading tool to improve radiologists' performance, said Bastarrika, a radiologist at the University of Navarra Clinic in Pamplona.

"CAD's use could potentially impact the detection and management of pulmonary nodules in lung cancer screening," he said.

For more information from the Diagnostic Imaging archives:

CAD breaks through in liver imaging

CAD acquisition parameters prove critical to accuracy

CT CAD review automatically measures lung nodule volume

Joint-read CAD systems make U.S. debut

Recent Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.